Dr Nánási Péter tudományos közleményeinek jegyzéke

Dr Nánási Péter tudományos közleményeinek jegyzéke I. In extenso angol nyelvû közlemények 1. Cseri J, Nánási PP, Varga E: Effects of phlorizin and phloretin on passive and dynamic electrical properties in muscle membrane. Acta Physiol Hung 1987;69:21-32 [IF=0.351] 2. Nánási PP, Varró A, Rabloczky G, Dankó M: Use-dependent blockade of sodium channels induced by bencyclane in frog skeletal muscle and canine cardiac Purkinje fiber. Arch Int Pharmacodyn 1987;290:278-287 [IF=0.827] 3. Nánási PP, Dankó M: Paradox response of frog muscle membrane to changes in external potassium. Pflügers Arch 1989;414:157-161 [IF=3.096] 4. Nánási PP, Bodnár Z, Dankó M: Effect of bencyclane on normal and cevadine-modified Na channels in frog skeletal muscle. Gen Physiol Biophys 1989;8:447-458 [IF=0.624] 5. Lathrop DA, Nánási PP, Varró A: In vitro models of dog Purkinje fibre triggered and spontaneous electrical activity: Effects of nicorandil. Br J Pharmacol 1990;99:119-123 [IF=4.666] 6. Nánási PP, Dankó M, Lathrop DA: Effect of antiarrhythmic drugs, TTX, and 4-aminopyridine on repetitive electrical activity in frog skeletal muscle. Gen Pharmacol 1990;21:563-567 [IF=1.227] 7. Nánási PP, Varró A, Lathrop DA, Dankó M: Use-dependent action of antiarrhythmic drugs in frog skeletal muscle and canine Purkinje fiber. Gen Pharmacol 1990;21:747-751 [IF=1.227] 8. Nánási PP, Kiss T, Lathrop DA, Dankó M: Different actions of veratrum alkaloids and aconitine in frog skeletal muscle. Gen Pharmacol 1990;21:863-868 [IF=1.227] 9. Varró A, Knilans TK, Nánási PP, Rabloczky G, Lathrop DA: Concentration- and rate-dependent effects of restacorin (GYKI-38 233) on isolated canine Purkinje fibers. Naunyn Schmiedeberg's Arch Pharmacol 1990;342:691-697 [IF=3.349] 10. Puppi A, Nánási PP, Dely M: Influence of the redox-state potential of biophase on electrically stimulated skeletal muscles. Acta Physiol Hung 1991;77:33-41 [IF=0.228] 11. Knilans TK, Varró A, Nánási PP, Murray RJ, Kaiser FC, Lathrop DA: Electrophysiological effects of FPL 13210 on canine Purkinje fiber action potential duration and V + max: comparison to disopyramide. Cardiovasc Drugs Ther 1991;5:139-146 [IF=0.519] 12. Varró A, Nánási PP, Lathrop DA: Effect of sotalol on transmembrane ionic currents responsible for repolarization in cardiac ventricular myocytes from rabbit and guinea pig. Life Sci 1991;49:PL7-PL12 [IF=1.766] 13. Knilans TK, Lathrop DA, Nánási PP, Schwartz A, Varró A: Rate and concentration dependent effects of UK-68,798, a new potent class III antiarrhythmic on canine Purkinje fiber action potential duration and V + max. Br J Pharmacol 1991;103:1568-1572 [IF=4.786] 1

14. Varró A, Nánási PP, Lathrop DA: Voltage clamp characteristics of ventricular myocytes in rabbit. Cardioscience 1991;2:233-243 [IF=0.762] 15. Nánási PP, Dankó M: Slow membrane potential changes in skeletal muscle induced in chloridefree medium. Acta Physiol Hung 1991;78:369-377 [IF=0.228] 16. Nánási PP, Dankó M: Repetitive electrical activity of the muscle membrane induced in chloride-free medium. Clin Exp Pharmacol Physiol 1992;19:127-136 [IF=0.970] 17. Nánási PP, Dankó M, Varró A, Lathrop DA: Nonlinear relationship between V + max and h- infinity during repetitive electrical activity of skeletal muscle. Gen Physiol Biophys 1992;11:159-167 [IF=0.573] 18. Nánási PP, Knilans TK, Richards IS, Varró A, Lathrop DA: Biphasic effect of tetraethylammonium on canine Purkinje fibre action potential configuration. Gen Pharmacol 1992;23:733-738 [IF=0.885] 19. Nánási PP, Knilans TK, Varró A, Murphy AM, Fujiki A, Schwartz A, Lathrop DA: Active and passive electrical properties of isolated canine cardiac Purkinje fibers under conditions simulating ischemia: effect of diltiazem. Pharmacol Toxicol 1992;71:52-56 [IF=0.992] 20. Nánási PP, Varró A, Lathrop DA: Ionic currents in ventricular myocytes isolated from the heart of a patient with idiopathic cardiomyopathy Cardioscience 1992;3:85-89 [IF=0.911] 21. Nánási PP, Varró A, Lathrop DA: Isolation of human ventricular and atrial cardiomyocytes. Cardioscience 1993;4:111-116 [IF=0.9] 22. Varró A, Lathrop DA, Hester SB, Nánási PP, Papp JGY: Ionic currents and action potentials in rabbit, rat and guinea pig ventricular myocytes. Basic Res Cardiol 1993;88:93-102 [IF=0.991] 23. Lathrop DA, Nánási PP, Schwartz A, Varró A: Ionic basis for OPC-8212 induced increase in action potential duration in isolated rabbit, guinea pig, and human ventricular myocytes. Eur J Pharmacol 1993;240:127-137 [IF=2.849] 24. Varró A, Nánási PP, Lathrop DA: Potassium currents in isolated human atrial and ventricular cardiocytes. Acta Physiol Scand 1993;149:133-142 [IF=1.621] 25. Nánási PP, Varró A, Lathrop DA, Bryant SH: Effects of veratridine on Na and Ca currents in frog skeletal muscle. Gen Pharmacol 1994;25:1661-1666 [IF=0.846] 26. Nánási PP, Varró A, Bryant SH, Lathrop DA: Effects of veratrine on ion currents in single rabbit cardiomyocytes. Gen Pharmacol 1994;25:1667-1672 [IF=0.846] 27. Nánási PP, Dely M: Effects of methylene-blue and ascorbate on transmembrane potential in frog skeletal muscle. Gen Pharmacol 1995;26:1307-1311 [IF=0.871] 28. Pankucsi C, Hegedüs M, Kovács A, Szemerédi K, Nánási PP: Electrophysiological effects of dridocainide on isolated canine, guinea pig and human cardiac tissues. Naunyn Schmiedeberg's Arch Pharmacol 1995;352:520-528 [IF=3.04] 2

29. Pankucsi C, Varró A, Nánási PP: Three distinct components of the negative inotropic action of lidocaine in dog Purkinje fiber. Gen Pharmacol 1996;27:69-71 [IF=0.818] 30. Lathrop DA, Varró A, Nánási PP, Bódi I, Takyi E, Pankucsi C: Differences in the effects of d- and dl-sotalol on isolated human ventricular muscle electromechanical activity after betaadrenoceptor stimulation. J Cardiovasc Pharmacol Ther 1996;1:65-74 [IF=1.00] 31. Szigligeti P, Pankucsi C, Bányász T, Varró A, Nánási PP: Action potential duration and forcefrequency relationship in isolated rabbit, guinea pig and rat cardiac muscle. J Comp Physiol B 1996;166:150-155 [IF=0.926] 32. Nánási PP, Varró A, Pankucsi C, Homolay P, Knilans TK, Kovács L, Papp JG, Lathrop DA: Electrical restitution in diseased human ventricular myocardium. Clin Physiol 1996;16:339-351 [IF=0.576] 33. Nánási PP, Pankucsi C, Bányász T, Szigligeti P, Papp JG, Varró A: Electrical restitution in rat ventricular muscle. Acta Physiol Scand 1996;158:143-153 [IF=1.519] 34. Kecskeméti V, Pacher P, Pankucsi C, Nánási P: Comparative study of cardiac electrophysiological effects of atrial natriuretic peptide. Mol Cell Biochem 1996;160/161:53-59 [IF=1.504] 35. Lathrop DA, Nánási PP, Varró A, Schwartz A: Comparison of the electromechanical effects of vesnarinone and amrinone in isolated dog Purkinje strands and ventricular trabeculae. J Cardiovasc Pharmacol Ther 1996;1:133-140 [IF=1.00] 36. Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Szénási G, Varró A, Nánási PP: Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues. Naunyn Schmiedeberg's Arch Pharmacol 1997;355:398-405 [IF=2.492] 37. Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Szénási G, Varró A, Nánási PP: Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated guinea pig papillary muscle. Gen Pharmacol 1997;29:275-280 [IF=1.056] 38. Bányász T, Magyar J, Szigligeti P, Pankucsi C, Varró A, Nánási PP: Frequency-dependent characteristics of human cardiac muscle. Exp Clin Cardiol 1997;2:205-209 39. Nánási PP, Szénási G: EGIS-7229, a new potent antiarrhythmic candidate with combined mode of action. Cardiovasc Drug Reviews 1998;15:314-334 [IF=0.524] 40. Szigligeti P, Bányász T, Magyar J, Szigeti Gy, Papp Z, Varró A, Nánási PP: Intracellular calcium and electrical restitution in mammalian cardiac cells. Acta Physiol Scand 1998;163:139-147 [IF=1.258] 41. Nánási PP, Varró A, Lathrop DA: Action potential duration and contractility in canine cardiac tissues: action of inotropic drugs. Gen Pharmacol 1998;31:415-418 [IF=1.037] 42. Pankucsi C, Magyar J, Bányász T, Mátyus P, Nánási PP: Novel antiarrhythmic agents with combined mode of action. IDrugs 1998;1:554-560 3

43. Bányász T, Magyar J, Varró A, Kovács A, Gyönös I, Szénási G, Nánási PP: EGIS-7229, the new combined class III antiarrhythmic agent: lack of EAD inducing effect. Gen Pharmacol 1999;32:329-333 [IF=1.105] 44. Pacher P, Ungvári Z, Nánási PP, Fürst S, Kecskeméti V: Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem 1999;6:469-480 [IF=3.0] 45. Pacher P, Ungvári Z, Nánási PP, Kecskeméti V: Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. Acta Physiol Scand 1999;166:7-13 [IF=1.411] 46. Pacher P, Ungvári Z, Nánási PP, Mucha I, Kecskeméti V, Losonczy Gy: Post-partum prolongation of the atrial repolarization in rabbit. Acta Physiol Scand 1999;166:1-5 [IF=1.411] 47. Szigeti Gy, Bányász T, Magyar J, Körtvély Á, Szigligeti P, Kovács L, Jednákovits A, Nánási PP: Effects of bimoclomol, the novel heat shock protein coinducer, in dog ventricular myocardium. Life Sci 2000;67:73-79 [IF=1.808] 48. Pacher P, Bagi Zs, Lakó-Futó Z, Ungvári Z, Nánási PP, Kecskeméti V: Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle: comparison to clomipramine. Gen Pharmacol 2000;34:17-23 [IF=1.14] 49. Jednákovits A, Kurucz I, Nánási PP: Effect of subchronic bimoclomol treatment on vascular responsiveness and heat shock protein production in spontaneously hypertensive rats. Life Sci 2000;67:1791-1797 [IF=1.808] 50. Körtvély Á, Szigeti Gy, Gesztelyi R, Zsuga J, Bányász T, Magyar J, Szigligeti P, Kovács L, Jednákovits A, Szentmiklósi AJ, Nánási PP: Cardiovascular effects of BRX-005: comparison to bimoclomol. Life Sci 2000;67:1783-1789 [IF=1.808] 51. Magyar J, Iost N, Körtvély Á, Bányász T, Virág L, Szigligeti P, Varró A, Papp JGy, Nánási PP: Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes. Pflügers Arch 2000;441:144-149 [IF=2.203] 52. Pacher P, Magyar J, Szigligeti P, Bányász T, Pankucsi C, Korom Z, Ungvári Z, Kecskeméti V, Nánási PP: Electrophysiological effects of fluoxetine in mammalian cardiac tissues. Naunyn Schmiedeberg's Arch Pharmacol 2000;361:67-73 [IF=2.869] 53. Magyar J, Bányász T, Szigligeti P, Körtvély Á, Jednákovits A, Nánási PP: Electrophysiological effects of bimoclomol in canine ventricular myocytes. Naunyn Schmiedeberg's Arch Pharmacol 2000;361:303-310 [IF=2.869] 54. Nánási PP, Sárközi S, Szigeti Gy, Jóna I, Szegedi Cs, Szabó Á, Bányász T, Magyar J, Szigligeti P, Körtvély Á, Csernoch L, Kovács L, Jednákovits A: Biphasic effect of bimoclomol on calcium handling in mammalian ventricular myocardium. Br J Pharmacol 2000;129:1405-1412 [IF=3.689] 55. Jednákovits A, Ferdinandy P, Jaszlits L, Bányász T, Magyar J, Szigligeti P, Körtvély Á, Szentmiklósi AJ, Nánási PP: In vivo and in vitro cardiovascular effects of bimoclomol. Gen Pharmacol 2000;34:363-369 [IF=0.778] 4

56. Kovács A, Gyönös I, Magyar J, Bányász T, Nánási PP, Spedding M, Szénási G: Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation. J Cardiovasc Pharmacol 2001;37:78-88 [IF=1.553] 57. Bányász T, Magyar J, Körtvély Á, Szigeti Gy, Szigligeti P, Papp Z, Mohácsi A, Kovács L, Nánási PP: Different effects of endothelin-1 on calcium and potassium currents in canine ventricular cells. Naunyn Schmiedeberg's Arch Pharmacol 2001;363:383-390 [IF=2.472] 58. Magyar J, Bányász T, Fülöp L, Szentandrássy N, Körtvély Á, Kovács A, Szénási G, Nánási PP: Effects of the antiarrhythmic agent EGIS-7229 on calcium and potassium currents in canine ventricular myocytes. Naunyn Schmiedeberg's Arch Pharmacol 2001;363:604-611 [IF=2.472] 59. Nánási PP, Jednákovits A: Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer bimoclomol: results of preclinical studies. Cardiovasc Drug Reviews 2001;19:133-151 [IF=0.632] 60. Magyar J, Szentandrássy N, Bányász T, Fülöp L, Varró A, Nánási PP: Effects of thymol on calcium and potassium currents in canine and human ventricular cardiomyocytes. Br J Pharmacol 2002;136:330-338 [IF=3.45] 61. Magyar J, Bányász T, Bagi Zs, Pacher P, Szentandrássy N, Fülöp L, Kecskeméti V, Nánási PP: Electrophysiological effects of risperidone in mammalian cardiac cells. Naunyn Schmiedeberg's Arch Pharmacol 2002;366:350-356 [IF=2.566] 62. Magyar J, Rusznák Z, Harasztosi C, Körtvély Á, Pacher P, Bányász T, Pankucsi C, Kovács L, Szûcs G, Nánási PP, Kecskeméti V: Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med 2003;11:535-542 [IF=1.94] 63. Bányász T, Fülöp L, Magyar J, Szentandrássy N, Varró A, Nánási PP: Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. Cardiovasc Res 2003;58:66-75 [IF=5.164] 64. Kovács A, Magyar J, Bányász T, Nánási PP, Szénási G: -adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea pig atrium in vitro. Br J Pharmacol 2003;139:1555-1563 [IF=3.611] 65. Szentandrássy N, Szentesi P, Magyar J, Nánási PP, Csernoch L: Effect of thymol on kinetic properties of Ca and K currents in rat skeletal muscle. BMC Pharmacology 2003;3:9. 66. Fülöp L, Fiák E, Szentandrássy N, Magyar J, Nánási PP, Bányász T: Role of transmembrane chloride current in afterdepolarizations in canine ventricular cardiomyocytes. Gen Physiol Biophys 2003;22:341-353 [IF=0.794] 67. Fülöp L, Szigeti Gy, Magyar J, Szentandrássy N, Ivanics T, Miklós Zs, Ligeti L, Kovács A, Szénási G, Csernoch L, Nánási PP, Bányász T: Differences in electrophysiological and contractile properties of mammalian cardiac tissues in bicarbonate- and HEPES-buffered solutions. Acta Physiol Scand 2003;178:11-18 [IF=1.724] 5

68. Szentandrássy N, Szigeti Gy, Szegedi Cs, Sárközi S, Magyar J, Bányász T, Csernoch L, Kovács L, Nánási PP, Jóna I: Effect of thymol on calcium handling in mammalian ventricular myocardium. Life Sci. 2004;74:909-921 [IF=2.158] 69. Fülöp L, Bányász T, Magyar J, Szentandrássy N, Varró A, Nánási PP: Reopening of L-type calcium channels in human ventricular myocytes during applied epicardial action potentials. Acta Physiol Scand 2004;180:39-47 [IF=2.086] 70. Bányász T, Koncz R, Fülöp L, Szentandrássy N, Magyar J, Nánási PP: Profile of I Ks during the action potential questions the therapeutic value of I Ks blockade. Curr Med Chem 2004;11:45-60 [IF=4.382] 71. Mohácsi A, Magyar J, Bányász T, Nánási PP: Effects of endothelins on cardiac and vascular cells. New therapeutic target for the future? Curr Vasc Pharmacol 2004;2:53-63 72. Magyar J, Szentandrássy N, Bányász T, Fülöp L, Varró A, Nánási PP: Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes. Eur J Pharmacol 2004;487:29-36 [IF=2.432] 73. Magyar J, Szentandrássy N, Bányász T, Kecskeméti V, Nánási PP: Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes. Naunyn Schmiedeberg's Arch Pharmacol 2004;370:203-210 [IF=1.963] 74. Varró A, Nánási PP, Acsai K, Virág L, Papp JGy: Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past perspectives of the future. Curr Pharmaceutical Design 2004;10:2411-2427 [IF=5.385] 75. Nagy ZsA, Virág L, Tóth A, Biliczki P, Acsai K, Bányász T, Nánási PP, Papp JGy, Varró A: Selectice inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed afterdepolarization in canine heart. Br J Pharmacol 2004;143:827-831 [IF=3.325] 76. Szentadrássy N, Bányász T, Bíró T, Szabó G, Tóth B, Magyar J, Lázár J, Varró A, Kovács L, Nánási PP: Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. Cardiovasc Res 2005;65:851-860 [IF=5.283] 77. Szabó G, Szentandrássy N, Bíró T, Tóth IB, Czifra G, Magyar J, Bányász T, Varró A, Kovács L, Nánási PP: Asymmetrical distribution of ion channels in canine and human left ventricular wall: epicardium versus midmyocardium. Pflügers Arch 2005;450:307-316 [IF=3.564] 78. Birinyi P, Acsai K, Bányász T, Tóth A, Horváth B, Virág L, Szentandrássy N, Magyar J, Varró A, Fülöp F, Nánási PP: Effects of SEA0400 and KB-R7943 on Na + /Ca 2+ exchange current and L- type Ca 2+ current in canine ventricular cardiomyocytes. Naunyn Schmiedeberg's Arch Pharmacol 2005;372:63-70 [IF=2.098] 79. Kecskeméti V, Rusznák Z, Riba P, Pál B, Wagner R, Harasztosi Cs, Nánási PP, Szûcs G: Norfluoxetine and fluoxetine have equal anticonvulsive and Ca 2+ channel blocking potencies. Brain Res Bull 2005;67:126-132 [IF=2.481] 80. Magyar J, Horváth B, Bányász T, Szentandrássy N, Birinyi P, Varró A, Szakonyi Zs, Fülöp F, Nánási PP: L-364,373 fails to activate the slow delayed rectifier K + current in canine ventricular 6

cardiomyocytes. Naunyn Schmiedeberg's Arch Pharmacol 2006;373:85-90 [IF=2.779] 81. Jóna I, Nánási PP: Cardiomyopathies and sudden cardiac death caused by RyR2 mutations: Are the channels the beginning and the end? Cardiovasc Res 2006;71:416-418 [IF=5.826] 82. Horváth B, Magyar J, Szentandrássy N, Birinyi P, Nánási PP, Bányász T: Contribution of I Ks to ventricular repolarization in canine myocytes. Pflügers Arch 2006;452:698-706 [IF=4.807] 83. Fülöp L, Bányász T, Szabó G, Tóth IB, Bíró T, Lôrincz I, Balogh Á, Petô K, Mikó I, Nánási PP: Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Scand) 2006;188:163-171 [IF=2.23] 84. Lengyel Cs, Virág L, Bíró T, Jost N, Pacher P, Magyar J, Biliczki P, Kecskeméti V, Nánási PP, Tóth M, Papp JGy, Varró A: Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Cardiovasc Res 2007; 73:512-520 [IF=6.127] 85. Gönczi M, Szentandrássy N, Fülöp L, Telek A, Szigeti GyP, Magyar J, Bíró T, Nánási PP, Csernoch L: Hypotonic stress influence the membrane potential and alter the proliferation of keratinocytes in vitro. Exp Dermatol 2007; 16:302-310 [IF=2.951] 86. Bányász T, Magyar J, Szentandrássy N, Horváth B, Birinyi P, Szentmiklósi J, Nánási PP: Action potential clamp fingerprints of K + currents in canine cardiomyocytes: their role in ventricular repolarization. Acta Physiol (Scand) 2007; 190:189-198 [IF=2.554] 87. Acsai K, Kun A, Farkas AS, Fülöp F, Nagy N, Balázs M, Szentandrássy N, Nánási PP, Papp JGy, Varró A, Tóth A: Effect of partial blockade of the Na + /Ca 2+ exchanger by SEA0400 on Ca 2+ handling in isolated rat ventricular myocytes. Eur J Pharmacol 2007; 576:1-6 [IF=2.376] 88. Szabó A, Szentandrássy N, Birinyi P, Horváth B, Szabó G, Bányász T, Márton I, Nánási PP, Magyar J: Effects of articaine on action potential characteristics and the underlying ion currents in canine ventricular myocytes. Br J Anaesthesia 2007;99:726-733 [IF=2.948] 89. Lengyel Cs, Virág L, Pacher P, Kocsis E, Nánási PP, Tóth M, Kecskeméti V, Papp JGy, Varró A, Jost N: Analysis of the electrophysiological effects of the alloxan induced diabetes mellitus in rabbit heart. Acta Physiol (Scand) 2008;192:359-368 [IF=2.455] 90. Farkas AS, Acsai K, Tóth A, Fülöp F, Seprényi Gy, Birinyi P, Nánási PP, Forster T, Csanády M, Papp JGy, Varró A, Farkas A: Na + /Ca 2+ exchanger inhibition exerts a positive inotropic effect in the rat heart, fails to influence the contractility of the rabbit heart. Br J Pharmacol 2008;154:93-104 [IF=4.902] 91. Birinyi P, Tóth A, Jóna I, Acsai K, Almássy J, Nagy N, Prorok J, Gherasim I, Papp Z, Hertelendi Z, Szentandrássy N, Bányász T, Fülöp F, Papp JGy, Varró A, Nánási PP, Magyar J: The Na + /Ca 2+ exchange blocker SEA0400 fails to enhance cytosolic Ca 2+ transient and contractility in canine ventricular cardiomyocytes. Cardiovasc Res 2008;78:476-484 [IF=5.947] 7

92. Szentandrássy N, Birinyi P, Szigeti Gy, Farkas A, Magyar J, Tóth A, Csernoch L, Varró A, Nánási PP: SEA0400 fails to alter the magnitude of intracellular Ca 2+ transients and contractions in Langendorff-perfused guinea pig heart. Naunyn Schmiedeberg's Arch Pharmacol 2008;378:65-71 [IF=2.83] 93. Szabó A, Szentandrássy N, Birinyi P, Horváth B, Szabó G, Bányász T, Márton I, Magyar J, Nánási PP: Effects of ropivacaine on action potential configuration and ion currents in isolated canine ventricular cardiomyocytes. Anesthesiology 2008;108:693-702 [IF=5.124] 94. Jost N, Acsai K, Horváth B, Bányász T, Bitay M, Bogáts G, Nánási PP: Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes. Is there any influence of action potential duration? Basic Res Cardiol 2009;104:33-41 [IF=5.973] 95. Nagy N, Szűts V, Horváth Z, Seprényi Gy, Farkas AS, Acsai K, Prorok J, Bitay M, Kun A, Pataricza J, Papp JGy, Nanasi PP, Varró A, Tóth A: Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? J Mol Cell Cardiol 2009;47:656-663 [IF=4.965] 96. Tóth A, Kiss L, Varró A, Nánási PP: Potential Therapeutic Effects of Na + /Ca 2+ Exchanger Inhibition in Cardiac Diseases. Curr Med Chem 2009;16:3294-3321 [IF=4.708] 97. Bányász T, Horváth B, Virág L, Bárándi L, Szentandrássy N, Harmati G, Magyar J, Marangoni S, Zaza A, Varró A, Nánási PP: Reverse rate dependency is an intrinsic property of canine cardiac preparations. Cardiovasc Res 2009;84:237-244 [IF= 5.801] 98. Szentandrássy N, Szabó A, Almássy J, Jóna I, Horváth B, Szabó G, Bányász T, Márton I, Nánási PP, Magyar J: Effects of articaine and ropivacaine on calcium handling and contractility in canine ventricular myocardium. Eur J Anaesthesiology 2010;27:153-161 [IF=1.679] 99. Bárándi L, Virág L, Jost N, Horváth Z, Koncz I, Papp R, Harmati G, Horváth B, Szentandrássy N, Bányász T, Magyar J, Zaza A, Varró A, Nánási PP: Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations. Basic Res Cardiol 2010;105:315-323 [IF=6.128] 100. Bárándi L, Harmati G, Horváth B, Szentandrássy N, Bányász T, Magyar J, Varró A, Nánási PP: Drug-induced changes in action potential duration are proportional to action potential duration in rat ventricular myocardium. Gen Physiol Biophys 2010;29:308-312 [IF=1.146] 101. Vasas G, Borbely G, Nánási P, Nánási PP: Alkaloids from cyanobacteria with diverse powerful bioactivities. Mini Rev Med Chem 2010;10:946-955 [IF=2.622] 102. Simkó J, Szentandrássy N, Harmati G, Bárándi L, Horváth B, Magyar J, Bányász T, Lőrincz I, Nánási PP: Effects of ropinirole on action potential characteristics and the underlying ion currents in canine ventricular myocytes. Naunyn Schmiedeberg's Arch Pharmacol 2010;382:213-220 [IF=2.5] 8

103. Harmati G, Papp F, Szentandrássy N, Bárándi L, Ruzsnavszky F, Horváth B, Bányász T, Magyar J, Panyi Gy, Krasznai Z, Nánási PP: Effects of the PKC inhibitor chelerythrine and GF- 109203X on delayed rectifier K + currents. Naunyn Schmiedeberg's Arch Pharmacol 2011;383:141-148 [IF=2.5] 104. Harmati G, Bányász T, Bárándi L, Szentandrássy N, Horváth B, Szabó G, Szentmiklósi JA, Szénási G, Nánási PP, Magyar J: Effects of ß-adrenergic stimulation on delayed rectifier K + currents in canine ventricular cardiomyocytes. Br J Pharmacol 2011;162:890-896 [IF=4.925] 105. Szentmiklósi AJ, Cseppentő A, Harmati G, Nánási PP: Novel trends in treatment of cardiovascular disorders: site- and event-selective adenosinergic drugs. Curr Med Chem 2011;18: 1164-1187 [IF=4.63] 106. Szentandrássy N, Harmati G, Bárándi L, Simkó J, Horváth B, Magyar J, Bányász T, Lőrincz I, Szebeni A, Kecskeméti V, Nánási PP: Effects of rosiglitazone on action potential configuration and ion currents in canine ventricular cells. Br J Pharmacol 2011;163:499-509 [IF= 4.925] 107. Virág L, Jost N, Papp R, Koncz I, Kristóf A, Kohajda Zs, Harmati G, Carbonell-Pascual B, Ferrero J, Papp JG, Nánási PP, Varró A: Analysis of the contribution of I to to repolarization in canine ventricular myocardium. Br J Pharmacol 2011;164:93-105 [IF= 4.925] 108. Borbíró I, Lisztes E, Tóth BI, Czifra G, Oláh A, Szöllôsi AG, Szentandrássy N, Nánási PP, Péter Z, Paus R, Kovács L, Bíró T: Activation of transient receptor potential vanilloid-3 inhibits human hair growth. J Invest Dermatol 2011;131:1605-1614 [IF=6.27] 109. Nánási PP, Kecskeméti V: Hot topics in cellular cardiac electrophysiology with potential impact on future drug design. Curr Med Chem 2011;18:3595-3596 [IF=4.63] 110. Bányász T, Bárándi L, Virág L, Szentandrássy N, Márton I, Zaza A, Varró A, Nánási PP: Mechanism of reverse rate-dependent action of cardioactive agents. Curr Med Chem 2011;18:3597-3606 [IF=4.63] 111. Szabó G, Farkas V, Grunnet M, Mohácsi A, Nánási PP: Enhanced repolarization capacity: new potential antiarrhythmic strategy based on HERG channel activation. Curr Med Chem 2011;18:3607-3621 [IF=4.63] 112. Nagy N, Márton Z, Kiss L, Varró A, Nánási PP, Tóth A: Role of Ca 2+ -sensitive K + currents in controlling ventricular repolarization: possible implications for future antiarrhytmic drug therapy. Curr Med Chem 2011;18:3622-3639 [IF=4.63] 113. Szentmiklósi AJ, Cseppentő Á, Gesztelyi R, Zsuga J, Körtvély Á, Harmati G, Nánási PP: Xanthine derivatives in the heart: blessed or cursed? Curr Med Chem 2011;18:3695-3706 [IF=4.63] 114. Bányász T, Szentandrássy N, Tóth A, Nánási PP, Magyar J, Chen-Izu Y: Cardiac calmodulin kinase: a potential target for drug design. Curr Med Chem 2011;18:3707-3713 [IF=4.63] 115. Magyar J, Jenes Á, Kistamás K, Ruzsnavszky F, Nánási PP, Satin J, Szentandrássy N, Bányász T: Long term regulation of cardiac L-type calcium channel by small G proteins. Curr Med Chem 2011;18:3714-3719 [IF=4.63] 9

116. Szebeni A, Szentandrássy N, Pacher P, Simkó J, Nánási PP, Kecskeméti V: Can the electrophysiological action of rosiglitazone explain its cardiac side effects? Curr Med Chem 2011;18:3720-3728 [IF=4.63] 117. Szentandrássy N, Harmati G, Farkas V, Horváth B, Hegyi B, Magyar M, Szénási G, Márton I, Nánási PP: Modified camp derivatives: powerful tools in heart research. Curr Med Chem 2011;18:3729-3736 [IF=4.63] 118. Szentandrássy N, Nagy D, Ruzsnavszky F, Harmati G, Bányász T, Magyar J, Szentmiklósi AJ, Nánási PP: Powerful technique to test selectivity of agents acting on cardiac ion channels: the action potential voltage clamp. Curr Med Chem 2011;18:3737-3756 [IF=4.63] 119. Pueyo E, Corrias A, Virág L, Jost N, Szél T, Varró A, Szentandrássy N, Péter Nánási, Burrage K, Rodríguez B: A multi-scale investigation of repolarization variability and its role in cardiac arrhythmogenesis. Biophys J 2011;101:2892-2902 [IF=4.218] 120. Péter Nánási Jr., Péter P. Nánási: Problems with class 3 antiarrhythmic agents: Conclusions of the past - perspectives of the future. Current Topics in Pharmacology 2011;15:11-18. 121. Gönczi M, Birinyi P, Balázs B, Szentandrássy N, Harmati G, Könczei Z, Csernoch L, Nánási PP: Age-dependent changes in ion channel mrna expression in canine cardiac tissues. Gen Physiol Biophys 2012; Közlésre elfogadva [IF=1.146] Fenti közlemények (1-121) összesített impakt faktora: 311.89 II. Idézhetô angol nyelvû absztraktok 1. Nánási PP, Dankó M: Effects of Ca-antagonists on membrane potential oscillation induced by cevadine. Acta Pharm Suecia 1985;S1:325-326 2. Nánási PP, Dankó M: Role of Cl and K ions in membrane potential changes evoked by cevadine. Acta Physiol Hung 1980;56:61 3. Nánási PP, Cseri J: Chloride dependence of phlorizin action on electrical and transport properties in frog skeletal muscle. Acta Physiol Hung 1984;63:362 4. Dankó M, Nánási PP, Varga E: Effects of antiarrhythmic drugs on the action potential parameters of skeletal muscle. Acta Physiol Hung 1985;66:240 5. Nánási PP, Dankó M: Antiarrhythmic effect of quinidine on skeletal muscle. Acta Physiol Hung 1988;71:144 6. Varró A, Nánási PP, Lathrop DA: Voltage clamp characterization of two normal populations of rabbit ventricular myocytes. Clin Res 1989;37(4):891A 10

7. Nánási PP, Dankó M, Varró A, Lathrop DA: Nonlinear relationship between V + max and h-infinity during repetitive electrical activity of skeletal muscle. Biophys J 1990;57:105A 8. Varró A, Nánási PP, Lathrop DA: Voltage clamp characterization of rabbit cardiac ventricular myocytes. Biophys J 1990;57:134A 9. Nánási PP, Knilans TK, Richards IS, Varró A, Lathrop DA: Biphasic effect of tetraethylammonium on canine Purkinje fiber action potential configuration. J Mol Cell Cardiol 1990;22:S3 10. Knilans TK, Lathrop DA, Varró A, Nánási PP, Schwartz A: Rate and concentration dependent effects of UK-68,798, a new potent class III antiarrhythmic on canine Purkinje fiber action potential duration and V + max. J Mol Cell Cardiol 1990;22:S16 11. Knilans TK, Varró A, Nánási PP, Murray RJ, Lathrop DA: Electrophysiological effects of FPL 13210 on canine Purkinje fiber action potential duration and V + max: comparison to disopyramide. J Mol Cell Cardiol 1990;22:S16 12. Nánási PP, Varró A, Bryant SH, Lathrop DA: Veratrine modified sodium channels in heart and skeletal muscle. Biophys J 1991;57:72A 13. Varró A, Nánási PP, Lathrop DA: Effect of sotalol on transmembrane ionic currents responsible for repolarization in cardiac ventricular myocytes from rabbit and guinea pig. J Mol Cell Cardiol 1991;23:S10 14. Lathrop DA, Nánási PP, Varró A, Schwartz A: Ionic basis for OPC-8212 (AKRIN-Z) induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes. J Mol Cell Cardiol 1991;24:S107 15. Nánási PP, Varró A, Lathrop DA: Ionic currents in isolated human cardiomyocytes. J Muscle Res Cell Motility 1992;13:248 16. Varró A, Lathrop DA, Hester SB, Nánási PP, Papp JG: Comparison of ionic currents and action potentials in rabbit, rat and guinea pig myocytes. J Mol Cell Cardiol 1993;25:S70 17. Nánási PP, Szigligeti P, Varró A, Pankucsi C: Force-frequency relationship in mammalian cardiac muscles. J Mol Cell Cardiol 1995;27:A126 18. Lathrop DA, Nánási PP, Bódi I, Takyi E, Pankucsi C: Differences in the effects of d- and dlsotalol on isolated human ventricular muscle electromechanical activity after beta-adrenoceptor stimulation. FASEB J 1995;9:A602 19. Pacher P, Kecskeméti V, Pankucsi C, Nánási PP: Cardiac electrophysiology of atrial natriuretic peptide in different specieses. J Mol Cell Cardiol 1996;28:A289 20. Kovács A, Gyönös I, Wellmann J, Nánási PP, Pankucsi C, Szénási G: Pharmacological effects of EGIS-7229, a new antiarrhytmic compound with combined mode of action. J Mol Cell Cardiol 1996;28:A59 11

21. Szénási G, Pankucsi C, Kovács A, Gyönös I, Bányász T, Magyar J, Szilvássy Z, Nánási PP: Electrophysiological, anti- and proarrhythmic effects of EGIS-7229, a novel antiarrhytmic drug with class III predominance. Eur Heart J 1997;18S:A254 22. Nánási PP, Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Szénási G: Electrophysiological properties of EGIS-7229, a new combined antiarrhythmic agent, in mammalian and human cardiac tissues. Cardiovasc Drugs Ther 1997;11-S2:318 23. Nánási PP, Bányász T, Magyar J, Mohácsi A: Effects of endothelin on action potential and potassium currents in canine ventricular myocytes. J Am Coll Cardiol 1998;31:359C 24. Nánási PP, Szigligeti P, Bányász T, Magyar J, Szigeti Gy, Papp Z: Intracellular calcium and electrical restitution in mammalian cardiac cells. J Am Coll Cardiol 1998;31:2C 25. Iost N, Magyar J, Virág L, Bányász T, Varró A, Mohácsi A, Nánási PP, Opincariu M, Szécsi J, Papp JGy: Effect of endothelin on electrophysiological properties of human and canine ventricular myocytes. J Mol Cell Cardiol 1998;30:A69 26. Kecskeméti V, Magyar J, Szigligeti P, Bányász T, Pankucsi Cs, Korom Zs, Ungvári Z, Nánási PP, Pacher P: Cardiac electrophysiological effects of fluoxetine. Fundamental Clin Pharmacol 1999;13:286S 27. Kecskeméti V, Pacher P, Magyar J, Szigligeti P, Bányász T, Ungvári Z, Nánási PP, Koller Á: Cardiac electrophysiological and vascular effects of fluoxetine. Eur Heart J 1999;20:575 28. Pacher P, Ungvári Z, Magyar J, Szigligeti P, Bányász T, Kecskeméti V, Nánási PP, Koller Á: Inhibition of cardiac Na and Ca channels by fluoxetine. FASEB J 1999;13:A97 29. Mohácsi A, Magyar J, Bányász T, Nánási PP: Endothelin interacts with adenylate cyclase and modifies electrophysiological effects of isoproterenol in isolated canine myocytes. J Heart Disease 1999;1:58 30. Nánási PP, Jóna I, Szigeti Gy, Jednákovits A: Biphasic effects of bimoclomol, a new heat shock protein coinducer, on calcium handling in mammalian ventricular myocardium. Eur Heart J 2000;21S:439 31. Bányász T, Magyar J, Nánási PP: Inhibitory role of chloride current on delayed afterdepolarization in canine ventricular myocytes. J Physiol (Lond) 2000;526P:81 32. Magyar J, Bányász T, Nánási PP: Effects of thymol on the ion currents in canine ventricular myocytes. J Physiol (Lond) 2000;526P:81-82 33. Nánási PP, Magyar J, Bányász T, Körtvély Á, Iost N, Virág L, Varró A: Effects of endothelin on potassium and calcium currents in isolated canine and human ventricular myocytes. J Physiol (Lond) 2000;526P:96-97 34. Nánási PP, Bányász T, Magyar J, Fülöp L, Szentandrássy N: Epi-endocardiac differences in calcium current profiles in canine and human myocytes. PACE 2003;26:S115 12

35. Varró A, Lengyel Cs, Virág L, Magyar J, Kecskeméti V, Tóth M, Bíró T, Nánási PP, Papp JGy: Diabetes attenuates the repolarisation reserve in the dog and rabbit hearts. Exp Clin Cardiol 2003;8:P52 36. Kecskeméti V, Magyar J, Bányász T, Bagi Zs, Pacher P, Szentandrássy N, Fülöp L,, Nánási PP: Can the electrophysiological actions of antipsychotic risperidone explain its cardiac side effects? Eur J Heart Failure 2003; Suppl.2/1:60-61 37. Nánási PP, Szentandrássy N, Bányász T, Magyar J: Effect of norfluoxetine on cardiac ion currents. Fundamental & Clin Pharmacol 2004; Suppl.1:26 38. Kecskeméti V, Riba P, Wágner R, Rusznák Z, Magyar J, Szûcs G, Nánási PP: Is norfluoxetine responsible for the anticonvulsant and inhibitory action on ionic currents of fluoxetine? Fundamental & Clin Pharmacol 2004; Suppl.1:139 39. Varró A, Lengyel Cs, Virág L, Magyar J, Bíró T, Iost N, Nánási PP, Tóth M, Kecskeméti V, Papp JGy: Diabetes attenuates the repolarisation reserve in the dog heart. Cardiovasc J South Africa 2004; Suppl.15:10 40. Nánási PP, Magyar J, Varró A: Effect of norfluoxetine in canine cardiomyocytes. Cardiovasc J South Africa 2004; Suppl.15:13 41. Fülöp L, Bányász T, Szabó G, Tóth IB, Bíró T, Lôrincz I, Balogh Á, Petô K, Mikó I, Nánási PP: Repolarization reserve is enhanced by testosterone but not by estrogen. Cardiologica Hung 2006; Suppl. 36 42. Varró A, Lengyel Cs, Virág L, Bíró T, Jost N, Pacher P, Magyar J, Kocsis E, Skoumal R, Nánási PP, Horkay F, Tóth M, Kecskeméti V, Papp JGy: Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Chinese J Pathophysiol 2006;22(13) 287 43. Fülöp L, Bíró T, Bányász T, Varró A, Nánási PP: Sex-hormone related differences in the ECG parameters of male and female dogs. Chinese J Pathophysiol 2006;22(13) 259 44. Kecskeméti V, Magyar J, Bányász T, Szentandrássy N, Pacher P, Nánási PP: Is the electrophysiological actions of psychotropic drugs responsible for their cardiac side effects? J Mol Cell Cardiol 2006;40:987-988. 45. Horváth B, Nánási PP, Bíró T, Bányász T, Szentandrássy N, Szabó G, Magyar J: Distribution of ion channels in the layers of human and canine left ventricular myocardium. Cardiol Hung 2007;37:A18. 46. Szabó G, Nánási PP, Bíró T, Bányász T, Szentandrássy N, Horváth B, Magyar J: Inhomogeneous distribution of ion channels and channel proteins in canine and human ventricular myocardium. Cardiol Hung 2007;37:A26. 47. Kecskeméti V, Szebeni A, Szentandrássy N, Nánási PP: Can the electrophysiological action of rosiglitazone explain its cardiac side effects? BMC Pharmacology 2011;11, Suppl 2:A54. 13

III. Könyvrészletek 1. Mohácsi A, Magyar J, Bányász T, Nánási PP: Endothelin-1 elektrofiziológiai hatása izolált emlôs-cardiomyocytán. In: Polgár P, Tenczer J, Merkely B (szerk): Ritmuszavarok, 37-41. Alföldi Nyomda, Debrecen, 1998. 2. Magyar J, Bányász T, Szigligeti P, Mohácsi A, Nánási PP: Electrophysiological effects of endothelin-1 in epicardiac and endocardiac canine ventricular myocytes. XIII. World Congress of Cardiology - Free Papers, Monduzzi Editor, 1998, 203-206. 3. Szigligeti P, Bányász T, Magyar J, Varró A, Nánási PP: Effect of chelation of cytosolic calcium on action potential duration and electrical restitution in dog rabbit and rat ventricular myocytes. XIII. World Congress of Cardiology - Free Papers, Monduzzi Editor, 1998, 207-211. 4. Édes I, Nánási PP, Tálosi L: A szívmûködés élettana és kórélettana. In: Temesvári András, Gyenes Gábor (szerk): Kardiológia 2000. 27-48. Melania, Budapest 2000. 5. Édes I, Nánási PP: A szívmûködés szabályozása. In: Tulassay Zsolt (szerk): A belgyógyászat alapjai. 522-524. Medicina, Budapest. 2007. 6. Szentandrássy N, Magyar J, Nánási PP: Electrical inhomogeneity in mammalian ventricular myocardium. In: Nanasi P (szerk): Advances in cardiomyocyte research, 47-92. Transworld Research Network, Kerala, 2010. 7. Nánási PP, Szentandrássy N, Tóth A, Bányász T: Power of the action potential voltage clamp technique. In: Nanasi P (szerk): Advances in cardiomyocyte research, 93-119. Transworld Research Network, Kerala, 2010. 8. Tóth A, Nánási PP, Varró A: Pharmacological modulation of the Na + /Ca 2+ exchanger in normal and diseased heart. In: Nanasi P (szerk): Advances in cardiomyocyte research, 179-226. Transworld Research Network, Kerala, 2010. 9. Chen-Izu Y, Izu LT, Nanasi PP, Banyasz T: From Action Potential-Clamp to "Onion-Peeling" Technique Recording of Ionic Currents Under Physiological Conditions. In: Kaneez FS (szerk): Patch Clamp Technique, 143-162. InTech, Rijeka, 2012. Publikációs tevékenység: - 120 db in extenso közlemény angol nyelvű folyóiratokban összesített impakt faktor: 311.89 független hivatkozások száma: 806-47 db idézhető absztrakt angol nyelvű folyóiratokban - 9 db könyvfejezet 14